IBDEI0RR ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13671,0)
 ;;=V10.60^^83^858^55
 ;;^UTILITY(U,$J,358.3,13671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13671,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,13671,1,5,0)
 ;;=5^  Leukemia
 ;;^UTILITY(U,$J,358.3,13671,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,13672,0)
 ;;=V10.11^^83^858^56
 ;;^UTILITY(U,$J,358.3,13672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13672,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,13672,1,5,0)
 ;;=5^  Lung/Bronchus
 ;;^UTILITY(U,$J,358.3,13672,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,13673,0)
 ;;=V10.79^^83^858^57
 ;;^UTILITY(U,$J,358.3,13673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13673,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,13673,1,5,0)
 ;;=5^  Lymphoma
 ;;^UTILITY(U,$J,358.3,13673,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,13674,0)
 ;;=V10.82^^83^858^58
 ;;^UTILITY(U,$J,358.3,13674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13674,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,13674,1,5,0)
 ;;=5^  Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,13674,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,13675,0)
 ;;=V10.02^^83^858^59
 ;;^UTILITY(U,$J,358.3,13675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13675,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,13675,1,5,0)
 ;;=5^  Oral/Pharynx
 ;;^UTILITY(U,$J,358.3,13675,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,13676,0)
 ;;=V10.43^^83^858^60
 ;;^UTILITY(U,$J,358.3,13676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13676,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,13676,1,5,0)
 ;;=5^  Ovary
 ;;^UTILITY(U,$J,358.3,13676,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,13677,0)
 ;;=V10.46^^83^858^61
 ;;^UTILITY(U,$J,358.3,13677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13677,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,13677,1,5,0)
 ;;=5^  Prostate
 ;;^UTILITY(U,$J,358.3,13677,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,13678,0)
 ;;=V10.06^^83^858^62
 ;;^UTILITY(U,$J,358.3,13678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13678,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,13678,1,5,0)
 ;;=5^  Rectum/Rectosigmoid/Anus
 ;;^UTILITY(U,$J,358.3,13678,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,13679,0)
 ;;=V10.52^^83^858^53
 ;;^UTILITY(U,$J,358.3,13679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13679,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,13679,1,5,0)
 ;;=5^  Kidney
 ;;^UTILITY(U,$J,358.3,13679,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,13680,0)
 ;;=V10.04^^83^858^64
 ;;^UTILITY(U,$J,358.3,13680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13680,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,13680,1,5,0)
 ;;=5^  Stomach
 ;;^UTILITY(U,$J,358.3,13680,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,13681,0)
 ;;=V10.47^^83^858^65
 ;;^UTILITY(U,$J,358.3,13681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13681,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,13681,1,5,0)
 ;;=5^  Testis/Scrotum
 ;;^UTILITY(U,$J,358.3,13681,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,13682,0)
 ;;=V10.83^^83^858^63
 ;;^UTILITY(U,$J,358.3,13682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13682,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,13682,1,5,0)
 ;;=5^  Skin
 ;;^UTILITY(U,$J,358.3,13682,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,13683,0)
 ;;=201.90^^83^858^67
 ;;^UTILITY(U,$J,358.3,13683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13683,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,13683,1,5,0)
 ;;=5^  Hodgkin's Lymphoma
 ;;^UTILITY(U,$J,358.3,13683,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,13684,0)
 ;;=200.20^^83^858^69
 ;;^UTILITY(U,$J,358.3,13684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13684,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,13684,1,5,0)
 ;;=5^  Lymphoma, Burkitt's
